189 related articles for article (PubMed ID: 28555086)
1. Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery.
Pardina E; Ferrer R; Rossell J; Ricart-Jané D; Méndez-Lara KA; Baena-Fustegueras JA; Lecube A; Julve J; Peinado-Onsurbe J
Int J Obes (Lond); 2017 Sep; 41(9):1388-1393. PubMed ID: 28555086
[TBL] [Abstract][Full Text] [Related]
2. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: relationship with metabolic outcomes.
Gómez-Ambrosi J; Andrada P; Valentí V; Rotellar F; Silva C; Catalán V; Rodríguez A; Ramírez B; Moncada R; Escalada J; Salvador J; Frühbeck G
Int J Obes (Lond); 2017 Sep; 41(9):1379-1387. PubMed ID: 28584299
[TBL] [Abstract][Full Text] [Related]
4. Roux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients.
Rega-Kaun G; Kaun C; Jaegersberger G; Prager M; Hackl M; Demyanets S; Wojta J; Hohensinner PJ
Obes Surg; 2020 Feb; 30(2):391-400. PubMed ID: 31728904
[TBL] [Abstract][Full Text] [Related]
5. Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese.
Pardina E; Ferrer R; Rossell J; Baena-Fustegueras JA; Lecube A; Fort JM; Caubet E; González Ó; Vilallonga R; Vargas V; Balibrea JM; Peinado-Onsurbe J
BBA Clin; 2016 Jun; 5():54-65. PubMed ID: 27051590
[TBL] [Abstract][Full Text] [Related]
6. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.
Sell H; Divoux A; Poitou C; Basdevant A; Bouillot JL; Bedossa P; Tordjman J; Eckel J; Clément K
J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212
[TBL] [Abstract][Full Text] [Related]
7. Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss.
Kayser BD; Lhomme M; Dao MC; Ichou F; Bouillot JL; Prifti E; Kontush A; Chevallier JM; Aron-Wisnewsky J; Dugail I; Clément K
Int J Obes (Lond); 2017 Jun; 41(6):917-925. PubMed ID: 28280270
[TBL] [Abstract][Full Text] [Related]
8. Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery.
Phillips ML; Boase S; Wahlroos S; Dugar M; Kow L; Stahl J; Slavotinek JP; Valentine R; Toouli J; Thompson CH
Diabetes Obes Metab; 2008 Aug; 10(8):661-7. PubMed ID: 17941875
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance predicts steatosis and fibrosis in morbidly obese patients undergoing bariatric surgery.
Aller R; de Luis D; Pacheco D; Velasco MC; Izaola O; Sagrado MG
J Investig Med; 2012 Oct; 60(7):1005-8. PubMed ID: 22847342
[TBL] [Abstract][Full Text] [Related]
10. Effect of Roux-en-Y gastric bypass-induced weight loss on the transcriptomic profiling of subcutaneous adipose tissue.
González-Plaza JJ; Gutiérrez-Repiso C; García-Serrano S; Rodriguez-Pacheco F; Garrido-Sánchez L; Santiago-Fernández C; García-Arnés J; Moreno-Ruiz FJ; Rodríguez-Cañete A; García-Fuentes E
Surg Obes Relat Dis; 2016 Feb; 12(2):257-63. PubMed ID: 26615868
[TBL] [Abstract][Full Text] [Related]
11. Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
Lalloyer F; Mogilenko DA; Verrijken A; Haas JT; Lamazière A; Kouach M; Descat A; Caron S; Vallez E; Derudas B; Gheeraert C; Baugé E; Despres G; Dirinck E; Tailleux A; Dombrowicz D; Van Gaal L; Eeckhoute J; Lefebvre P; Goossens JF; Francque S; Staels B
J Hepatol; 2023 Oct; 79(4):898-909. PubMed ID: 37230231
[TBL] [Abstract][Full Text] [Related]
12. Regression of hepatic steatosis in morbidly obese persons after gastric bypass.
Silverman EM; Sapala JA; Appelman HD
Am J Clin Pathol; 1995 Jul; 104(1):23-31. PubMed ID: 7611176
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
15. Relationship of the nutritional status of vitamin A and the regression of hepatic steatosis after Roux-en-Y gastric bypass surgery for treatment of class III obesity.
Oliveira e Silva LG; Manso JE; Silva RA; Pereira SE; Saboya Sobrinho CJ; Rangel CW
Arq Bras Cir Dig; 2012; 25(4):250-6. PubMed ID: 23411924
[TBL] [Abstract][Full Text] [Related]
16. Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children.
Knøsgaard L; Kazankov K; Birkebæk NH; Holland-Fischer P; Lange A; Solvig J; Hørlyck A; Kristensen K; Rittig S; Vilstrup H; Grønbæk H; Handberg A
Eur J Clin Nutr; 2016 Sep; 70(9):1073-7. PubMed ID: 27273071
[TBL] [Abstract][Full Text] [Related]
17. Should we wait for metabolic complications before operating on obese patients? Gastric bypass outcomes in metabolically healthy obese individuals.
Pelascini E; Disse E; Pasquer A; Poncet G; Gouillat C; Robert M
Surg Obes Relat Dis; 2016 Jan; 12(1):49-56. PubMed ID: 26164112
[TBL] [Abstract][Full Text] [Related]
18. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.
Klein S; Mittendorfer B; Eagon JC; Patterson B; Grant L; Feirt N; Seki E; Brenner D; Korenblat K; McCrea J
Gastroenterology; 2006 May; 130(6):1564-72. PubMed ID: 16697719
[TBL] [Abstract][Full Text] [Related]
19. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
Emery MG; Fisher JM; Chien JY; Kharasch ED; Dellinger EP; Kowdley KV; Thummel KE
Hepatology; 2003 Aug; 38(2):428-35. PubMed ID: 12883487
[TBL] [Abstract][Full Text] [Related]
20. Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women.
Iannelli A; Anty R; Piche T; Dahman M; Gual P; Tran A; Gugenheim J
Obes Surg; 2009 May; 19(5):577-82. PubMed ID: 19018603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
